IMSC 2018
26.08. - 31.08.2018
Italy, Florence
http://www.imsc2018.it/
Gold Sponsor
Join us for the 22th International Mass Spectrometry Conference in Florence
Booth #6-8
As the fastest growing company in the Mass Spectrometry field, Shimadzu continues to play the role of game changer during this IMSC. Recognised for our robust Ultra-Fast Mass Technologies in tandem MS, we have released a new Q-TOF designed to deliver high resolution accurate-mass detection with incredibly fast data acquisition rates allowing you to identify and quantify more compounds with more confidence.
Take the chance to discover how the New LCMS-9030 Q-TOF will transform your daily analysis on booth #6-7-8!
Our experts look forward to welcoming you at our booth to discuss our latest innovations and answer your questions about our solutions for science.
Lunch Symposium
"Rethinking mass spectrometry: Brining together ultrafast technologies and better ways to solve analytical challenges"
We kindly invite you to participate in our free lunch symposia to get insights into latest technologies in mass spectrometry as well as new development in the field of New Born Screening. Just reserve your seat for these opportunities in advance and follow the registration link below.
Thursday, 30.08.2018
12:30-1:45 h
Spadolini Pavilion Room 3 (Upper Floor)
- "Results from a DPiMS-2020 (PESI-MS instrument) for real-time hepatocellular carcinoma identification"
Prof. Enrico Davoli, Mass Spectrometry Laboratory, Environmental Heath Sciences Department, Mario Negri Institute, Milan - Italy
- "Newborn screening for LSDs"
Prof. Giancarlo Lamarca, Associate Professor of Clinical Chemistry, Department of Experimental and Clinical Biomedical Sciences, University of Florence.
Head, Newborn Screening, Clinical Chemistry and Pharmacology Lab Meyer Children's Hospita
- "A new QTOF technology designed to unlock new workflows, new solutions"
Neil Loftus, General Manager, Shimadzu - Mass Spectrometry Business Unit Overseas
Registration closed. Thanks for your interest!
Poster Presentation
MP-27 Quantitation of monoclonal antibody infliximab in human plasma by LC-MS/MS using Fab-selective limited proteolysis nSMOL technology
N. Loftus, A. Barnes, A. Jaffuel - Shimadzu, MS/BU, Manchester, United Kingdom
MP-139 Development and validation of a high sensitivity assay of estrogens in human plasma by UHPLC-MS/MS without derivatization
M. Levi, H. Kobayashi, J. Watanabe - Shimadzu Corporation, MS BU, Kyoto, Japan
TP-105 Applying a novel component detection algorithm to help accelerate metabolomics discovery workflows
C. Hinz, E. G. Armitage, K. Hobby, N. Loftus, N. Gray, M. Y Schar, J. P. E. Spencer - Shimadzu UK Limited, LCMS technical department, Milton Keynes, United Kingdom
WP-29 Characterization of deuterated alpha-crystalline using bench-top MALDI-ToFMS
Y. Yamazaki, K. Morishima, N. Sato, R. Inoue, M. Sugiyama - Shimadzu Corp., Global application development center, Kyoto, Japan
WP-143 Complementary bioimaging to determine nanoparticle and phospholipid distribution in lung tissue
A. Niehoff, D. Dietrich, M. Sperling, U. Karst - Shimadzu Europa GmbH, Innovation Center, Duisburg, Germany
WP-157 Two dimensional metabolic profile of bile acids and lipids in fibrosis of NASH-model liver using MALDI Imaging at 20 μm spatial resolution
Y. Yamazaki, S. Yamaguchi, T. Oshikawa, D. Miura, M. Yamazaki - Shimadzu Corp., Global application development center, Kyoto, Japan
ThP-85 Determination of pyrrolizidine alkaloids in plant material using on-line SPE coupled to UHPLC-MS/MS
A. Grüning, J. Sander, S. Vedder - Shimadzu Europa, CIPS, Duisburg, Germany
ThP-107 Development of a comprehensive panel of eicosanoids and related fatty acid metabolites for high-sensitivity and quantitative LC-MS/MS analysis
Y. Fujito, M. Yamada, H. Lin, S. Fujita - Shimadzu Corporation, Global Application Development Center, Kyoto, Japan
Product Lineup
- LCMS-9030: “A Q-TOF of Shimadzu’s engineering DNA! ”
Ultra-fast acquisition rates and core ion beam technologies- Ultra-fast (UF) acquisition rates and core ion beam technologies developed for the triple quadrupole platform has opened-up new possibilities in quantitative mass spectrometry.
- The new LCMS-9030 Q-TOF builds on this proven platform by rethinking time-of-flight detection.
- In the LCMS-9030, core ion beam technologies transition towards a unique approach in ion gating using UFaccumulation to create a precise pulse of ions into the flight tube.
- MALDI-8020: "benchtop linear MALDI-TOF mass spectrometer"
A high performance benchtop linear MALDI-TOF mass spectrometer designed for routine MALDI-based workflows. Sample throughput is improved through the use of a solid-state laser for faster acquisitions and a load-lock system for rapid target introduction.